E-ISSN 2231-3206 | ISSN 2320-4672
 
2024, Vol: 14, Issue: 10
14 / 10Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles
Required files to be uploaded

Authorship Declaration

Original Research
Online Published: 27 Jun 2024
 


Can serum procalcitonin be used for severity identification and guiding treatment of children admitted with community-acquired pneumonia? – A cross-sectional study

Ambika Debbarma, Neha Karar, Prativa Biswas, Dipanjan Halder, Sudipta Banerjee, Moumita Pati, Dipanwita Mukhopadhyay, Esha Mukhopadhyay.


Abstract
Background: Community-acquired pneumonia (CAP) remains one of the leading causes of mortality and morbidity in children under 5 years of age. Early diagnosis and effective management remain the cornerstone to reduce complications and fatalities associated with CAP. Lately, C-reactive protein (CRP) and procalcitonin (PCT) have gained much attention as useful biomarkers in CAP. Recent data suggest that a very low PCT value has a high negative predictive value while identifying a population of children at low risk of typical bacterial infections. Hence, we propose to take up this study to assess the clinical utility of PCT in pediatric CAP.

Aims and Objectives: The aim of this study was to study serum PCT level in children with the clinical diagnosis of CAP admitted at R.G Kar Medical College and Hospital, Kolkata, and its role in severity identification and contribution in the treatment of CAP.

Materials and Methods: This cross-sectional hospital-based observational study was performed from January 2020 to June 2021 in the R.G Kar Medical College and Hospital, Kolkata, West Bengal, India. A total of 50 children were included within the age group of 2 months–5 years with CAP admitted in the Children’s ward and intensive care unit at our hospital. Clinical characteristics such as age, sex, symptoms such as history of fever, difficulty feeding or drinking, convulsion, lethargy, cyanosis, chest in-drawing, respiratory rates, auscultatory findings such as air entry of bilateral lungs, added sounds like-(inspiratory crept, bronchial breathing), and oxygen saturation were studied. Routine investigations such as complete blood count, serum CRP, blood culture, and chest radiograph sent along with serum PCT.

Results: Out of 50 children diagnosed with CAP, 30 (60%) fell within the age range of 2–5 months of age. Among the study population, 70% of children displayed weakly positive and 20% strongly positive serum PCT values. A strong correlation (P < 0.001) was revealed between the severity of pneumonia and PCT, and also a positive correlation (P < 0.001) between clinical outcome and PCT. However, the role in contribution in early diagnosis could not be concluded.

Conclusion: This study concluded that serum PCT may be used as a valuable indicator for assessing the severity and prognosis of CAP. All children with elevated PCT who were prescribed antibiotics did not experience further complications of CAP.

Key words: Pneumonia; Community-acquired Pneumonia; Procalcitonin; C-Reactive Protein


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Ambika Debbarma
Articles by Neha Karar
Articles by Prativa Biswas
Articles by Dipanjan Halder
Articles by Sudipta Banerjee
Articles by Moumita Pati
Articles by Dipanwita Mukhopadhyay
Articles by Esha Mukhopadhyay
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Debbarma A, Karar N, Biswas P, Halder D, Banerjee S, Pati M, Mukhopadhyay D, Mukhopadhyay E. Can serum procalcitonin be used for severity identification and guiding treatment of children admitted with community-acquired pneumonia? – A cross-sectional study. Natl J Physiol Pharm Pharmacol. 2024; 14(10): 2140-2146. doi:10.5455/njppp.2024.14.06242202416062024

Web Style

Debbarma A, Karar N, Biswas P, Halder D, Banerjee S, Pati M, Mukhopadhyay D, Mukhopadhyay E. Can serum procalcitonin be used for severity identification and guiding treatment of children admitted with community-acquired pneumonia? – A cross-sectional study. https://www.njppp.com/?mno=204755 [Access: October 03, 2024]. doi:10.5455/njppp.2024.14.06242202416062024

AMA (American Medical Association) Style

Debbarma A, Karar N, Biswas P, Halder D, Banerjee S, Pati M, Mukhopadhyay D, Mukhopadhyay E. Can serum procalcitonin be used for severity identification and guiding treatment of children admitted with community-acquired pneumonia? – A cross-sectional study. Natl J Physiol Pharm Pharmacol. 2024; 14(10): 2140-2146. doi:10.5455/njppp.2024.14.06242202416062024


Vancouver/ICMJE Style

Debbarma A, Karar N, Biswas P, Halder D, Banerjee S, Pati M, Mukhopadhyay D, Mukhopadhyay E. Can serum procalcitonin be used for severity identification and guiding treatment of children admitted with community-acquired pneumonia? – A cross-sectional study. Natl J Physiol Pharm Pharmacol. (2024), [cited October 03, 2024]; 14(10): 2140-2146. doi:10.5455/njppp.2024.14.06242202416062024


Harvard Style

Debbarma, A., Karar, . N., Biswas, . P., Halder, . D., Banerjee, . S., Pati, . M., Mukhopadhyay, . D. & Mukhopadhyay, . E. (2024) Can serum procalcitonin be used for severity identification and guiding treatment of children admitted with community-acquired pneumonia? – A cross-sectional study. Natl J Physiol Pharm Pharmacol, 14 (10), 2140-2146. doi:10.5455/njppp.2024.14.06242202416062024


Turabian Style

Debbarma, Ambika, Neha Karar, Prativa Biswas, Dipanjan Halder, Sudipta Banerjee, Moumita Pati, Dipanwita Mukhopadhyay, and Esha Mukhopadhyay. 2024. Can serum procalcitonin be used for severity identification and guiding treatment of children admitted with community-acquired pneumonia? – A cross-sectional study. National Journal of Physiology, Pharmacy and Pharmacology, 14 (10), 2140-2146. doi:10.5455/njppp.2024.14.06242202416062024


Chicago Style

Debbarma, Ambika, Neha Karar, Prativa Biswas, Dipanjan Halder, Sudipta Banerjee, Moumita Pati, Dipanwita Mukhopadhyay, and Esha Mukhopadhyay. "Can serum procalcitonin be used for severity identification and guiding treatment of children admitted with community-acquired pneumonia? – A cross-sectional study." National Journal of Physiology, Pharmacy and Pharmacology 14 (2024), 2140-2146. doi:10.5455/njppp.2024.14.06242202416062024


MLA (The Modern Language Association) Style

Debbarma, Ambika, Neha Karar, Prativa Biswas, Dipanjan Halder, Sudipta Banerjee, Moumita Pati, Dipanwita Mukhopadhyay, and Esha Mukhopadhyay. "Can serum procalcitonin be used for severity identification and guiding treatment of children admitted with community-acquired pneumonia? – A cross-sectional study." National Journal of Physiology, Pharmacy and Pharmacology 14.10 (2024), 2140-2146. Print. doi:10.5455/njppp.2024.14.06242202416062024


APA (American Psychological Association) Style

Debbarma, A., Karar, . N., Biswas, . P., Halder, . D., Banerjee, . S., Pati, . M., Mukhopadhyay, . D. & Mukhopadhyay, . E. (2024) Can serum procalcitonin be used for severity identification and guiding treatment of children admitted with community-acquired pneumonia? – A cross-sectional study. National Journal of Physiology, Pharmacy and Pharmacology, 14 (10), 2140-2146. doi:10.5455/njppp.2024.14.06242202416062024




Most Viewed Articles
Most Accessed Articles

  • Applications of computer science in Pharmacy: An overview
    Shivraj Popat Jadhav, Komal Nikam, Anand Gandhi, Kishor Salunkhe, Narendra Shinde.
    Natl J Physiol Pharm Pharmacol. 2012; 2(1): 1-9
    » Abstract

  • How to calculate sample size in animal studies?
    Hitesh Shah
    Natl J Physiol Pharm Pharmacol. 2011; 1(1): 35-39
    » Abstract

  • Chlorhexidine:The gold standard in chemical plaque control [English]
    Setu mathur, Tanu mathur,Rahul shrivastava, Rohit khatri
    Natl J Physiol Pharm Pharmacol. 2011; 1(2): 45-50
    » Abstract

  • Assessment of Nutritional Status of Pregnant Women Attending the City Tebessa PMI (Algeria) [English]
    Taleb Salima, Kaibi Mounira, Deghboudj Nadjia
    Natl J Physiol Pharm Pharmacol. 2011; 1(2): 97-105
    » Abstract

  • Difference in pulmonary function test among the athletic and sedentary population
    ShobhaRani Vedala, Niranjan Paul, Abhay B Mane
    Natl J Physiol Pharm Pharmacol. 2013; 3(2): 118-123
    » Abstract » doi: 10.5455/njppp.2013.3.109-114

    •
    Most Downloaded
    Top Downloaded Articles

  • How to calculate sample size in animal studies?
    Hitesh Shah
    Natl J Physiol Pharm Pharmacol. 2011; 1(1): 35-39
    » Abstract

  • Applications of computer science in Pharmacy: An overview
    Shivraj Popat Jadhav, Komal Nikam, Anand Gandhi, Kishor Salunkhe, Narendra Shinde.
    Natl J Physiol Pharm Pharmacol. 2012; 2(1): 1-9
    » Abstract

  • Evaluation of potential drug-drug interaction in indoor patients of pediatric department of tertiary care hospital
    Simran Patel, Mayur Chaudhari, Nrupal Patel
    Natl J Physiol Pharm Pharmacol. 2019; 9(10): 1012-1016
    » Abstract » doi: 10.5455/njppp.2019.9.0725209072019

  • Chlorhexidine:The gold standard in chemical plaque control [English]
    Setu mathur, Tanu mathur,Rahul shrivastava, Rohit khatri
    Natl J Physiol Pharm Pharmacol. 2011; 1(2): 45-50
    » Abstract

  • Analyzing Pharmaceutical Industry [English]
    Veselin Tima Dickov, Dragan Mitrovic, Boris Milan Kuzman
    Natl J Physiol Pharm Pharmacol. 2011; 1(1): 1-8
    » Abstract » doi: 10.5455/njppp.2011.1.1-8

    •
    Most Cited Articles
    Most Cited Articles

    About National Journal of Physiology, Pharmacy and Pharmacology

      National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal.  The journal is having open access polic ... Read more.



    For best results, please use Internet Explorer or Google Chrome.

    Contact Information

    Eldaghayes Publisher

    www.eldagpublisher.com 

     
    All correspondence should be addressed to:
    Prof. Ibrahim Eldaghayes
    Editor-in-Chief
    National Journal of Physiology, Pharmacy and Pharmacology
    Email: ibrahim.eldaghayes@vetmed.edu.ly
    POLICIES & JOURNAL LINKS
    Author Login
    Reviewer Login
    About Publisher
    Advertising Policy
    Author's Rights and Obligations
    Conflict of Interest Policy
    Copyright Information
    Digital Archiving & Preservation Policies
    Editorial Policies
    Peer Review Policy
    Editorial & Peer Review Process
    License Information
    Open Access Policy
    Plagiarism Policy
    Privacy Policy
    Protection of Research Participants (Statement On Human And Animal Rights)
    Publication Ethics and Publication Malpractice Statement
    Corrections, Retractions & Expressions of Concern
    Self-Archiving Policies
    Statement of Informed Consent
    Terms of Use